Related Experiment Video

Updated: Aug 29, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.8K

Evasion of neutralising antibodies by omicron sublineage BA.2.75

Daniel J Sheward1, Changil Kim2, Julian Fischbach2

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 65, Sweden; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

The Lancet. Infectious Diseases
|September 4, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.8K

Related Experiment Videos

Last Updated: Aug 29, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.8K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.8K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K

Articles linked to this work by shared authors, journal, and citation graph.

VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

The Journal of infectious diseases·2026

The physicochemical basis of protein evolution: property-informed evolutionary models (PRIME).

Molecular biology and evolution·2026

Imprints of Asymptotic Freedom on Confining Strings.

Physical review letters·2026

Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

Nature communications·2026

One-step generation of T-cell receptor knock-in mice in the TCRβ locus.

The EMBO journal·2026

Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.

Nature·2026

Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.

The Lancet. Infectious diseases·2026

The risk of mpox false positive results in high transmission settings: evidence from a multi-site observational study in DR Congo.

The Lancet. Infectious diseases·2026

Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial.

The Lancet. Infectious diseases·2026

Is a tiered classification framework needed for sexually transmitted infections?

The Lancet. Infectious diseases·2026

Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

The Lancet. Infectious diseases·2026

Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study.

The Lancet. Infectious diseases·2026

Introduction: Biofilms in cancer- an underestimated threat.

Progress in molecular biology and translational science·2026

A compact Druantia defense clears phage infections via single-stranded DNA recognition and directional duplex unwinding.

Cell reports·2026

Methods for Identifying Type III Secretion System Effectors in Chlamydia trachomatis.

Methods in molecular biology (Clifton, N.J.)·2026

Performance of a rapid direct-from-blood antibiotic susceptibility test based on MIC test strips on Enterobacterales blood cultures.

The Journal of antimicrobial chemotherapy·2026

A WOPR transcriptional regulatory network controls the virulence of the opportunistic fungal pathogen Nakaseomyces glabratus.

Microbiology spectrum·2026

Frankia root nodules.

Current biology : CB·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us